Primary Palliative Care for Emergency Medicine
急诊医学的初级姑息治疗
基本信息
- 批准号:10171791
- 负责人:
- 金额:$ 165.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-05-15 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:Accident and Emergency departmentAcuteAddressAdmission activityAdvanced Malignant NeoplasmAmbulatory CareAmericanAttentionCaringCessation of lifeCharacteristicsChronic DiseaseClinicalCommunicationConsultationsDataDay CareEducationEducational workshopElderlyEmergency CareEmergency MedicineEmergency SituationEmergency department visitEquilibriumEventFeedbackGeographic LocationsGoalsHealthHeterogeneityHomeHospitalizationInpatientsIntensive Care UnitsInterventionKnowledgeLifeMeasuresMedicare claimMedicare/MedicaidOutcomePalliative CarePatient CarePatientsPhaseProtocols documentationProviderQuality of lifeRandomizedRandomized Controlled TrialsReach, Effectiveness, Adoption, Implementation, and MaintenanceReadinessResearchResourcesSentinelSiteTestingTraining and EducationVariantacute carebasecare coordinationcare providerscare systemsclinical decision supportcomorbiditydemographicsdesigneffectiveness testingend of life careevidence basefunctional statushealth care service utilizationhigh riskhospice environmentimplementation fidelityimplementation frameworkimprovedindexinginjuredinnovationinpatient servicemedical specialtiesmultidisciplinaryoutpatient programspragmatic trialprogramsroutine practicescreeningsimulationskillstreatment as usualusability
项目摘要
Project Abstract
Emergency medicine developed as a specialty to treat the acutely ill and injured, but increasingly cares
for older adults with multiple comorbid conditions. An Emergency Department (ED) visit is a sentinel event for
older adults, often signifying a breakdown in care coordination and worsening clinical and functional status.
Half of Americans 65 years and older are seen in the ED in the last month of life, and three-quarters visit the
ED in the 6 months before death. Meanwhile, the number and rate of admissions to the Intensive Care Unit
(ICU) by emergency providers have been increasing, especially among older adults. Three-quarters of older
adults with serious illness have thought about end-of-life care, and only 12% want life-prolonging care.
Emergency providers impact a patient's clinical trajectory by balancing the potential harms and benefits of
hospitalization and connecting seriously ill, older adults with outpatient services. Until recently, little attention
has been paid to aligning care plans with patient goals for older adults in the ED. To address this gap in the
delivery of goal-directed emergency care of seriously ill, older adults, our team conducted a randomized
controlled trial of ED-initiated palliative care consultation in advanced cancer that showed improvement in
quality of life at 12 weeks. We also showed in a Center for Medicare and Medicaid Innovation project that ED-
based primary palliative care innovations reduced the percentage of geriatric ED admissions to the ICU from
2.3% to 0.9% through screening for high-risk older adults, early referral to palliative care and hospice, and
emergency provider training and education in palliative care principles. Whether this approach will be feasible
and effective in EDs with great heterogeneity in resources is unknown. We will tailor `primary palliative care
for emergency medicine' (PRIM-ER) for implementation in a diverse group of 35 EDs that vary in specialty
geriatric and palliative care capacity, geographic region, payer mix, and demographics. This proposal builds
upon existing research partnerships to implement and evaluate PRIM-ER on ED disposition, healthcare
utilization, and survival in older adults with serious, life-limiting illness. Our hypothesis is that older adult
visitors with serious, life-limiting illness cared for by providers with primary palliative care skills will be less likely
to be admitted to an inpatient setting, more likely to be discharged home or to a palliative care service, and will
have higher home health and hospice use, fewer inpatient days and ICU admissions at 6 months, and longer
survival than those seen prior to implementation. We propose a pragmatic, cluster-randomized stepped wedge
design to test the effectiveness of PRIM-ER in 35 EDs. PRIM-ER includes: 1) evidence-based,
multidisciplinary primary palliative care education, 2) simulation-based workshops on communication in
serious illness, 3) clinical decision support, and 4) provider audit and feedback. The specific aims are divided
into a: 1) UG3 Phase, in which we will tailor the protocols to a diverse ED context and pilot test the intervention
at two sites; and a 2) UH3 Phase in which we will test the intervention in a stepped wedge design in 33 EDs.
项目摘要
急诊医学发展成为一种治疗急病和伤员的专业,但也越来越受到关注
适用于患有多种并存疾病的老年人。急诊科(ED)访问是一种哨兵事件
老年人,通常意味着护理协调能力的崩溃以及临床和功能状况的恶化。
一半65岁及以上的美国人在生命的最后一个月会去急诊室,四分之三的人会去
死前6个月的ED。与此同时,重症监护病房的入院人数和入院率
急救人员的重症监护病房(ICU)一直在增加,尤其是在老年人中。四分之三的老年人
患有严重疾病的成年人考虑过临终关怀,只有12%的人想要延长生命的护理。
急诊提供者通过平衡以下各项的潜在危害和益处来影响患者的临床轨迹
住院并将重病老年人与门诊服务联系起来。直到最近,很少有人关注
一直致力于使护理计划与急诊室老年人的患者目标保持一致。为了解决这一差距,
为重症老年人提供有目标的急救服务,我们团队进行了一项随机的
ED启动的晚期癌症姑息治疗咨询的对照试验显示
12周时的生活质量。我们还在医疗保险和医疗补助创新中心的一个项目中展示了Ed-
基于初级姑息治疗的创新降低了老年急诊室入住ICU的比例
2.3%至0.9%,通过筛查高危老年人,及早转介到姑息治疗和临终关怀,以及
急救提供者在姑息治疗原则方面的培训和教育。这种方法是否可行?
而在资源异质性很大的EDS中是否有效,目前尚不清楚。我们将量身定做初级姑息治疗
用于急救医学(PRIM-ER),在由35名不同专业的急救人员组成的不同小组中实施
老年和姑息治疗能力、地理区域、支付者组合和人口统计。这项建议建立了
在现有研究伙伴关系的基础上实施和评估关于ED处置、医疗保健的Prim-ER
对患有严重、限制生命的疾病的老年人的利用率和存活率。我们的假设是老年人
由具有初级姑息护理技能的提供者护理的患有严重、限制生命的疾病的访客将不太可能
住进住院环境,更有可能出院或接受姑息治疗服务,并将
家庭健康和临终关怀使用率更高,住院天数和6个月内入住ICU的人数更少,而且更长时间
存活率高于实施前的水平。我们提出了一种实用的、集群随机的阶梯楔形
设计在35个急诊室中测试PRIM-ER的有效性。PRIM-ER包括:1)以证据为基础,
多学科初级姑息关怀教育,2)以模拟为基础的交流讲习班
严重疾病,3)临床决策支持,以及4)提供者审计和反馈。具体目标是有分歧的
进入:1)UG3阶段,在此阶段,我们将针对不同的ED环境定制协议,并对干预进行试点测试
在两个地点;和2)UH3阶段,在33个急诊室中,我们将以阶梯式楔形设计测试干预。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Keith Goldfeld其他文献
Keith Goldfeld的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Keith Goldfeld', 18)}}的其他基金
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 165.61万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 165.61万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 165.61万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 165.61万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 165.61万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 165.61万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 165.61万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 165.61万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 165.61万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 165.61万 - 项目类别:
Operating Grants